Official Publications ResMed, Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:02 05/12/2025 GMT			5-day change	1st Jan Change
256.55 ^USD	+2.00%		+0.28%	+12.18%

12-04	Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	MT
12-02	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI

11-17	Shareholders meeting voting results	CO
10-29	Slide show Q1	CO
10-29	SEC Filing 10Q-1	CO
10-29	1st quarter results	CO
10-01	Proxy Statments	CO
08-07	SEC Filing 10K	CO
07-30	Annual results	CO
07-30	Slide show results	CO
04-30	Acquisition	CO
04-22	SEC Filing 10Q-3	CO
04-22	3rd quarter results	CO
04-20	Changes in management and corporate officers	CO
01-29	SEC Filing 10Q-2	CO
01-29	Slide show half-year results	CO
01-29	1st-half-year results	CO
23/10/24	SEC Filing 10Q-1	CO
23/10/24	Slide show Q1	CO
23/10/24	1st quarter results	CO
08/08/24	SEC Filing 10K	CO
31/07/24	Annual results	CO
31/07/24	Slide show results	CO
24/04/24	SEC Filing 10Q-3	CO
24/04/24	Slide show Q3	CO
24/04/24	3rd quarter results	CO
23/01/24	SEC Filing 10Q-2	CO

ResMed's innovation-driven success and prospects

October 31, 2025 at 08:55 am